Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNTC
DateTimeSourceHeadlineSymbolCompany
08/03/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
08/03/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
08/03/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
06/03/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
26/02/202414:06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
23/02/202421:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
13/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
13/02/202413:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
07/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
30/11/202312:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
17/11/202313:00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
13/11/202313:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
13/11/202313:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
13/11/202313:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
20/10/202321:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
20/10/202311:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
16/10/202322:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
28/09/202322:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
21/09/202313:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
21/09/202313:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
21/09/202313:00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
18/09/202322:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
14/08/202322:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
11/08/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
11/08/202318:00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
10/08/202321:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
10/08/202321:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
10/08/202321:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
09/08/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
09/08/202303:30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC